The government has amended the Drugs Rules, 1945 to bring stem cell derived products, gene therapies, and xenografts under central licensing. This enhances regulatory oversight for cutting-edge treatments like CAR-T therapy, ensuring patient safety and faster adoption of emerging medical technologies.
Exam Lens
Quick Exam Facts From News
1-Minute Revision
- ›Regulation Amended: Drugs Rules, 1945
- ›Governing Act: Drugs and Cosmetics Act
- ›Target this Data: Amendment to Drugs Rules, 1945
- ›Target this Nodal Body: Central Licensing Approving Authority (CLAA) under Drugs and Cosmetics Act
- ›Target this Legal Point: Drugs and Cosmetics Act, 1940 and Drugs Rules, 1945
Mastered this topic? Test your knowledge with a full MCQ quiz.
Practice exam-style questions, track your score, and strengthen your recall.